Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats

Journal of Neurochemistry

Volumn 81, Issue 5, 2002, Pages 1084-1091

  Hashimoto, Michio ^a   Hossain, Shahdat ^a,d   Shimada, Toshio ^a   Sugioka, Kozo ^b   Yamasaki, Hiroshi ^a   Fujii, Yoshimi ^a   Ishibashi, Yutaka ^a   Oka, Jun Ichiro ^c   Shido, Osamu ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d JAHANGIRNAGAR UNIVERSITY   (Bangladesh)

Author keywords

Alzheimer's disease model rats; Antioxidative defence; Avoidance learning; Docosahexaenoic acid; Rat brain

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; DOCOSAHEXAENOIC ACID; FATTY ACID; GLUTATHIONE REDUCTASE; LIPID PEROXIDE; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN CORTEX; BRAIN VENTRICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIET; DISEASE MODEL; ENZYME ACTIVITY; HIPPOCAMPUS; LEARNING; LEARNING DISORDER; LIPID PEROXIDATION; MALE; MEMORY; NONHUMAN; OSMOTIC PUMP; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL; PROPHYLAXIS; RAT; TASK PERFORMANCE;

ADMINISTRATION, ORAL; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; ARACHIDONIC ACID; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BODY WEIGHT; CEREBRAL CORTEX; DIET; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; DRUG EVALUATION, PRECLINICAL; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; MALE; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; TREATMENT OUTCOME;

ANIMALIA;

EID: 0036319034     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.00905.x     Document Type: Article

References (42)

1. 2 production
2. Changes in antioxidant enzymes activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease
3. Mechanisms of emotional arousal and lasting declarative memory
4. Glutathione reductase
5. Wnt signaling function in Alzheimer's disease
6. Incorporation of arachidonic and docosahexaenoic acids into phospholipids of rat brain membranes
7. The effect of dietary docosahexaenoate on the learning ability of rats
8. Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats
9. Chronic administration of docosahexaenoic acid improves the performance of radial arm maze task in aged rats
10. Impaired cued and contextual memory in NPAS2-deficient mice
11. Intraamniotic ethyl docosahexaenoate administration protects fetal rat brain from ischemic stress
12. Mechanisms of docosahexaenoic acid accretion in the fetal brain
13. Reactive oxygen species and the central nervous system
14. Docosahexaenoic acid reduces GABA response in substantia nigra neuron of rat
15. The hypotensive effect of docosahexaenoic acid is associated with the enhanced release of ATP from the caudal artery of aged rats
16. Effects of docosahexaenoic acid on annular lipid fluidity of the rat bile canalicular plasma membrane
17. Fluorometric method for determination of oxidized and reduced glutathione in tissues
18. Antioxidative effects of docosahexaenoic acid in the cerebrum versus cerebellum and brainstem of aged hypercholesterolemic rats
19. Dysfunction of cholingeric and dopaminergic neuronal systems in β-amyloid protein-infused rats
20. Impairments of long-term potentiation in hippocampal slices of β-amyloid-infused rats
21. Aluminium promotes the aggregation of Alzheimer's amyloid β-protein in vitro
22. Direct transesterification of all classes of lipids in a one-step reaction
23. Intakes of dietary docosahexarnoic acid ethyl ester and egg phosphatidylcholine improve maze-learning ability in young and old mice
24. Protein measurement with the folin reagent
25. Docosahexaenoic acid - A new therapeutic approach to peroxisomal-disorder patients: Experience with two cases
26. Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats
27. Effects of purified eicosapentaenoic acid on arachidonic acid metabolism in cultured murine aortic smooth muscle cells, vessel walls and platelets
28. Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys
29. β-amyloid protein-induced Alzheimer's disease animal model
30. Continuous infusion of β-amyloid protein into cerebral ventricle induces learning impairment and neuronal and morphological degeneration
31. F4 isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease
32. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
33. Endogenous GLP-1 modulates hippocampal activity in β-amyloid protein-treated rats
34. Endogenous GLP-1 is involved in β-amyloid protein induced memory impairment and hippocampal neuronal death in rats
35. The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficit following transient forebrain ischemia in rats
36. Lipiods of nervous tissue: Composition and metabolism
37. Essential fatty acids in health and chronic disease
38. Fatty acid composition of brain phospholipids in aging and in Alzheimer's Disease
39. Protective effects of idebenone and α-tocopherol on amyloid-(1-42)-induced learning and memory deficits in rats: Implication of oxidative stress in b-amyloid-induced neurotoxicity in vivo
40. Effect of dietary alpha-linolenate/linoleate balance on brain lipid compositions and learning ability of rats
41. The antioxidant vitamin E modulates amyloid beta-peptide-induced creatine kinase activity inhibition and increased protein oxidation: Implications for the free radical hypothesis of Alzheimer's disease